Eco Animal Health Group PLC (LSE:EAH) Share Price

Company Profile

Business description
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.
Contact
100 High street
The Grange
Southgate
LondonN14 6BN
GBR
T: +44 2084478899
E: [email protected]
https://www.ecoanimalhealth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
227

Recommended

Tesla shares started the year on a sour note. We think they continue to price in ambitious growth going forward.

Seth Goldstein, CFA | 03 January 2025

Exploring the ASX sectors that moved the market this year.

Simonelle Mody | 18 December 2024

Two companies that show promising signs of handsomely rewarding shareholders.

Joseph Taylor | 17 December 2024

Index	Last price	Change	% Change
All Ordinaries	8,511.90	46.90	0.55%
CAC 40	7,282.22	111.54	-1.51%
DAX 40	19,906.08	118.58	-0.59%
Dow JONES (US)	42,732.13	339.86	0.80%
FTSE 100	8,223.98	36.11	-0.44%
HKSE	19,760.27	136.95	0.70%
NASDAQ	19,621.68	340.88	1.77%
Nikkei 225	39,894.54	386.62	-0.96%
NZX 50 Index	13,067.83	42.91	-0.33%
S&P 500	5,942.47	73.92	1.26%
S&P/ASX 200	8,250.50	49.30	0.60%
SSE Composite Index	3,211.43	51.13	-1.57%